Insmed, Inc. INSM – Options Review
We originally submitted our idea for the INSM options chain on Tuesday morning, tagging the INSM 09/15 $27-30 Calls on the heels of the company’s release of promising Phase-3 topline study results for its rare lung disease treatment.
Yesterday morning we updated our readers after the stock had made a marginal move which allowed for notable gains in just one of the four contracts in our observed range. However, we doubled down with our interest in these plays, mentioning that it seemed likely for the stock to provide a better chance at more sweeping gains and that’s just what happened.
The following moves were made yesterday afternoon which facilitated solid potential profits for anyone who was following along with the action. Those highly impressive gains were as follows:
$27 Calls – Range: .95-3.00 – Max Gain: 215%
$28 Calls – Range: .25-2.00 – Max Gain: 700%
$29 Calls – Range: .40-1.60 – Max Gain: 300%
$30 Calls – Range: .50-1.55 – Max Gain: 210%
______
Fresh Ideas:
GoPro, Inc. GPRO – Weekly $9.50 & $10 Calls
Trivago N.V. TRVG – 10/20 $15 & 17.50 Calls
NXT-id, Inc. NXTD
We’re seeing a sizable gap-up taking place in the premarket this morning on NXTD. The big boost in activity is stemming from a huge news announcement published today concerning a deal the company struck with Bank of America to get its ‘FitPay’ contact-less device payment solutions installed in more than 9,000 Bank of America ATMs. (>>View PR)
With a blockbuster announcement such as this, we’re definitely going to want to observe the action as we head into week’s end and beyond.
Extended Watchlist:
CLNT, MNKD, PTN, IRT, COGT, ADAP, NLNK